Improving the quality of substance dependency treatment with pharmacotherapy.
This article provides an overview of current pharmacological treatments for alcohol, opioid, cocaine, and nicotine use disorders. Guidelines for a "patient-treatment" matching framework to physicians working with various "substance-abusing" patients are presented, as well as recommendations regarding when to initiate and discontinue pharmacotherapy. Standard and newer pharmacological treatments for substance dependence are reviewed, as well as therapies that may be especially useful when treating the patient with comorbid substance dependency and psychiatric disorders. To maximize the therapeutic benefits of substance dependency treatment, patients should be individually assessed and provided adjunctive medications as clinically indicated. Specific areas for future laboratory and/or clinical research are recommended.
Boyarsky
B K
BK
Albert Einstein College of Medicine, Bronx, New York 10467, USA.
McCance-Katz
E F
EF
D000437:Alcoholism / Q000534:rehabilitation*; D019970:Cocaine-Related Disorders / Q000534:rehabilitation; D003131:Combined Modality Therapy; D015897:Comorbidity; D006801:Humans; D001523:Mental Disorders / Q000534:rehabilitation; D009293:Opioid-Related Disorders / Q000534:rehabilitation; D011619:Psychotropic Drugs / Q000627:therapeutic use*; D011785:Quality Assurance, Health Care; D016540:Smoking Cessation; D019966:Substance-Related Disorders / Q000534:rehabilitation*
D011619:Psychotropic Drugs